Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinomaxil versus placebo for acute infectious rhinosinusitis in adults not requiring antibiotics
2009-014421-16Phase 3Active
- Sponsor
- Zambon
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute rhinosinusitis (ARS) comparing Rhinomaxil with Placebo (2 arms). Primary endpoint: Change in nasal obstruction discomfort from baseline to day 4 evening. Started Aug 2009; status: active.
02
Drugs
beclomethasone dipropionate
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on 2009-014421-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014421-16.